These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10934485)

  • 1. The consequences of incontinentia pigmenti.
    Greaves S
    Nat Cell Biol; 2000 Aug; 2(8):E144. PubMed ID: 10934485
    [No Abstract]   [Full Text] [Related]  

  • 2. NF-kappa B defects in humans: the NEMO/incontinentia pigmenti connection.
    Courtois G; Israël A
    Sci STKE; 2000 Nov; 2000(58):pe1. PubMed ID: 11752619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEMO/IKK gamma-deficient mice model incontinentia pigmenti.
    Schmidt-Supprian M; Bloch W; Courtois G; Addicks K; Israël A; Rajewsky K; Pasparakis M
    Mol Cell; 2000 Jun; 5(6):981-92. PubMed ID: 10911992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.
    Makris C; Godfrey VL; Krähn-Senftleben G; Takahashi T; Roberts JL; Schwarz T; Feng L; Johnson RS; Karin M
    Mol Cell; 2000 Jun; 5(6):969-79. PubMed ID: 10911991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incontinentia pigmenti: the first single gene disorder due to disrupted NF-kappa B function.
    Kenwrick S
    Ernst Schering Res Found Workshop; 2002; (36):95-107. PubMed ID: 11859566
    [No Abstract]   [Full Text] [Related]  

  • 6. NEMO/IKK gamma: linking NF-kappa B to human disease.
    Courtois G; Smahi A; Israël A
    Trends Mol Med; 2001 Oct; 7(10):427-30. PubMed ID: 11597506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
    Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-kappaB signaling pathway in human genetic diseases.
    Courtois G
    Cell Mol Life Sci; 2005 Aug; 62(15):1682-91. PubMed ID: 15924263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From gene to disease; incontinentia pigmenti and the NEMO-gene].
    Oranje AP; Arts WF; Wagner A; van der Hout AH; Simonsz HJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1682-5. PubMed ID: 16104114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking out NEMO.
    Weitzman JB
    Mol Med Today; 2000 Sep; 6(9):339. PubMed ID: 11202969
    [No Abstract]   [Full Text] [Related]  

  • 11. Nail dystrophy, an unusual presentation of incontinentia pigmenti.
    Nicolaou N; Graham-Brown RA
    Br J Dermatol; 2003 Dec; 149(6):1286-8. PubMed ID: 14674911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
    Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
    Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEMO, NFkappaB signaling and incontinentia pigmenti.
    Nelson DL
    Curr Opin Genet Dev; 2006 Jun; 16(3):282-8. PubMed ID: 16647846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
    Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
    Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
    Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
    Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
    Berlin AL; Paller AS; Chan LS
    J Am Acad Dermatol; 2002 Aug; 47(2):169-87; quiz 188-90. PubMed ID: 12140463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incontinentia pigmenti with a foreshortened hand: evidence for the significance of NFkappaB in human morphogenesis.
    Kmetz EC; Shashidhar Pai G; Burges GE
    Pediatr Dermatol; 2009; 26(1):83-6. PubMed ID: 19250414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEMO mutational analysis in a Japanese family with incontinentia pigmenti.
    Tada H; Yoshida S; Yamaji Y; Fujisawa K; Ishibashi T
    Eye (Lond); 2007 Jun; 21(6):888-90. PubMed ID: 17401323
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and molecular genetic challenges in male incontinentia pigmenti: a case report.
    Gregersen PA; Sommerlund M; Ramsing M; Gjørup H; Rasmussen AA; Aggerholm A
    Acta Derm Venereol; 2013 Nov; 93(6):741-2. PubMed ID: 23572116
    [No Abstract]   [Full Text] [Related]  

  • 20. Incontinentia pigmenti in a father and daughter.
    Rashidghamat E; Hsu CK; Nanda A; Liu L; Al-Ajmi H; McGrath JA
    Br J Dermatol; 2016 Nov; 175(5):1059-1060. PubMed ID: 27037530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.